The Effect of Patient Advocacy Training on Advocacy Skills, Ethical Sensitivity, and Patient Safety Culture in Nurses
Launched by SELCUK UNIVERSITY · May 5, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how patient advocacy training can improve nurses’ skills in supporting patients, increase their understanding of ethical issues, and enhance the overall culture of safety in hospitals. The main goal is to see if this training makes a difference in how nurses advocate for their patients and ensure they receive the best care possible.
The study is open to nurses who work in a hospital and do not have any barriers to participating in the training. However, nurses who have been employed at the hospital for at least six months are not eligible to join. Participants can expect to take part in training sessions designed to boost their advocacy skills and help create a safer environment for patients. Since the study is not yet recruiting, it is important to check back for updates if you or someone you know is interested in participating.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: Employees who have no obstacles to participating in the training program Exclusion Criteria: Having worked in the hospital for at least six months
About Selcuk University
Selçuk University is a prominent educational institution located in Turkey, recognized for its commitment to advancing medical research and clinical studies. As a clinical trial sponsor, Selçuk University leverages its extensive academic resources and expertise to conduct innovative research that aims to address significant healthcare challenges. The university fosters collaboration among researchers, healthcare professionals, and industry partners to facilitate the development of new therapies and improve patient outcomes. Through rigorous adherence to ethical standards and regulatory guidelines, Selçuk University strives to contribute to scientific knowledge and enhance the quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Neslihan Ş Doctoral student, Doctoral student
Principal Investigator
Selcuk University
Neslihan Ş ŞAHİN, Doctoral student
Principal Investigator
Selcuk University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported